MBX Biosciences：我不该将其降级为持有（评级上调）（纳斯达克：MBX）
· seekingalpha.com
MBX Biosciences因canvuparatide的二期数据强劲、三期路径明确以及现金充裕的催化剂，评级上调至买入。点击查看MBX股票最新动态。
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...